Exploring the current use of animal models in glaucoma drug discovery: where are we in 2023?

Expert Opin Drug Discov. 2023 Jul-Dec;18(11):1287-1300. doi: 10.1080/17460441.2023.2246892. Epub 2023 Aug 22.

Abstract

Introduction: Animal models are widely used in glaucoma-related research. Since the elevated intraocular pressure (IOP) is a major risk factor underlying the disease pathogenesis, animal models with high IOP are commonly used. However, models are also used to represent the clinical context of glaucomatous changes developing despite a normal IOP.

Areas covered: Herein, the authors discuss the various factors that contribute to the quality of studies using animal models based on the evaluation of studies published in 2022. The factors affecting the quality of studies using animal models, such as the animal species, age, and sex, are discussed, along with various methods and outcomes of studies involving different animal models of glaucoma.

Expert opinion: Translating animal research data to clinical applications remains challenging. Our observations in this review clearly indicate that many studies lack scientific robustness not only in their experiment conduct but also in data analysis, interpretation, and presentation. In this context, ensuring the internal validity of animal studies is the first step in quality assurance. External validity, however, is more challenging, and steps should be taken to satisfy external validity at least to some extent.

Keywords: Glaucoma; animal models; intraocular pressure; optic neuropathy; retinal ganglion cells.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Disease Models, Animal
  • Drug Discovery
  • Glaucoma* / drug therapy
  • Glaucoma* / pathology
  • Intraocular Pressure*
  • Models, Animal
  • Optic Nerve / pathology
  • Retinal Ganglion Cells / pathology